New Approaches to Immunomodulation and Diagnostics
Speakers:
Alison Manchester, DVM, MS, DACVIM (SAIM)
Event date: 11 April 2024
Chronic enteropathy in dogs is a common clinical problem with a poorly understood pathogenesis. While most chronic enteropathy research to date has focused on immune cells, a broader view is needed so that patients can be better categorized and receive tailored treatments.
Research at Colorado State University has focused on transcriptomic studies of cells present in the duodenal mucosa of both healthy dogs and those with chronic enteropathy. In this session, Dr. Alison Manchester discusses the findings of her research and identifies potential future studies to enable individualized management of this disease.
Related Content
Gut Barrier Function and Immune Tolerance in Healthy and Allergic Dogs
Discover what is currently known about the role of acute intestinal injury in the development of chronic enteropathies and food allergies in dogs.
Impact of Nutrition on Allergy and Tolerance in Dogs
Epithelial barrier dysfunction, oxidant injury, and inflammation are common to both atopic dermatitis and chronic inflammatory enteropathy in dogs. These shared features are attractive targets for nutritional approaches to patient management.
The Relationship Between the Intestinal Microbiome, Dysbiosis, and Inflammation in Dogs and Cats
Chronic enteropathy in dogs and cats is characterized by overlapping unspecific features that often result from persistent dysbiosis and irreversible changes in intestinal function. Learn why different patients respond differently to therapy.